As of 2026-10-02, the Relative Valuation of VistaGen Therapeutics Inc (VTGN) is (32.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.28 USD, the upside of VistaGen Therapeutics Inc based on Relative Valuation is -11559.8%.
The range of the Relative Valuation is (20.89) - (41.97) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.5x - 22.2x | 17.8x |
| Forward P/E multiples | 9.2x - 21.1x | 14.7x |
| Fair Price | (20.89) - (41.97) | (32.39) |
| Upside | -7490.7% - -14951.9% | -11559.8% |
| Date | P/E |
| 2026-10-02 | -0.14 |
| 2026-10-01 | -0.14 |
| 2026-09-30 | -0.15 |
| 2026-09-29 | -0.15 |
| 2026-09-28 | -0.15 |
| 2026-09-25 | -0.14 |
| 2026-09-24 | -0.15 |
| 2026-09-23 | -0.18 |
| 2026-09-22 | -0.13 |
| 2026-09-21 | -0.12 |
| 2026-09-18 | -0.12 |
| 2026-09-17 | -0.12 |
| 2026-09-16 | -0.12 |
| 2026-09-15 | -0.12 |
| 2026-09-14 | -0.12 |
| 2026-09-11 | -0.12 |
| 2026-09-10 | -0.12 |
| 2026-09-09 | -0.12 |
| 2026-09-08 | -0.12 |
| 2026-09-04 | -0.12 |
| 2026-09-03 | -0.12 |
| 2026-09-02 | -0.12 |
| 2026-09-01 | -0.12 |
| 2026-08-31 | -0.13 |
| 2026-08-28 | -0.13 |
| 2026-08-27 | -0.13 |
| 2026-08-26 | -0.13 |
| 2026-08-25 | -0.12 |
| 2026-08-24 | -0.12 |
| 2026-08-21 | -0.12 |
| 2026-08-20 | -0.12 |
| 2026-08-19 | -0.12 |
| 2026-08-18 | -0.12 |
| 2026-08-17 | -0.13 |
| 2026-08-14 | -0.13 |
| 2026-08-13 | -0.13 |
| 2026-08-12 | -0.13 |
| 2026-08-11 | -0.14 |
| 2026-08-10 | -0.13 |
| 2026-08-07 | -0.14 |
| 2026-08-06 | -0.14 |
| 2026-08-05 | -0.15 |
| 2026-08-04 | -0.15 |
| 2026-08-03 | -0.12 |
| 2026-07-31 | -0.12 |
| 2026-07-30 | -0.12 |
| 2026-07-29 | -0.12 |
| 2026-07-28 | -0.12 |
| 2026-07-27 | -0.12 |
| 2026-07-24 | -0.11 |